Lumic
Get app
NIFTY 50·22,811.35−0.34%SENSEX·73,709.69−0.19%BANK NIFTY·54,976.90−0.92%RELIANCE·1,209.00+0.58%HDFC BANK·706.95−0.71%ICICI BANK·1,385.00+0.29%BHARTI AIRTEL·1,891.70+0.88%INFOSYS·1,168.00+3.30%L&T·3,636.00−0.71%TCS·2,529.00+2.77%ITC·262.00+0.46%SBI·963.00−1.10%AXIS BANK·1,210.00−2.10%NIFTY 50·22,811.35−0.34%SENSEX·73,709.69−0.19%BANK NIFTY·54,976.90−0.92%RELIANCE·1,209.00+0.58%HDFC BANK·706.95−0.71%ICICI BANK·1,385.00+0.29%BHARTI AIRTEL·1,891.70+0.88%INFOSYS·1,168.00+3.30%L&T·3,636.00−0.71%TCS·2,529.00+2.77%ITC·262.00+0.46%SBI·963.00−1.10%AXIS BANK·1,210.00−2.10%

Nifty

Indian Pharma Stocks Fall on Trump's Generic Drug Tariff Plan

3 months ago · Lumic

Indian pharma stocks decline on US tariff news. Nifty Pharma index falls.
Lumic
3 months ago
Indian Pharma Stocks Fall on Trump's Generic Drug Tariff Plan
KEY POINTS
Nifty Pharma declined as Trump's proposed tariff plan weighed on export outlook.
Imported generic drugs stay duty-free for two years before phased US tariffs begin.
India's major drugmakers face long-term uncertainty in their largest export market.
LUMIC INSIGHT
Pharma shares likely to be under pressure in coming days
Business Standard·3 months ago

This Fin Shorts piece explores the recent downturn in Indian pharma stocks, a significant development for the Indian stock market. The Nifty Pharma index saw a decline following pronouncements from US President Trump regarding potential tariffs on generic drugs. While imported generic drugs will remain duty-free for a couple of years, the proposed phased tariffs introduce long-term uncertainty for India's leading drug manufacturers, who rely heavily on the US as their primary export destination. This news highlights the interconnectedness of global trade policies and their impact on key sectors within the Indian economy, particularly the booming pharmaceutical sector. Investors and industry watchers are closely monitoring how these tariff impacts might affect export outlook and overall market sentiment for Indian pharma companies.

More in Nifty

Lumic Insights cover explaining why a company's share price can fall despite good sales or profits, introducing the role of
1/5
Lumic
4 days ago

Nifty

Why Stocks Fall Despite Good Results: Expectations vs Reality

Lumic research·4 days ago
Nifty IT records an 11.5% weekly gain, its biggest in nearly 18 years, as stronger quarterly results revive investor interest
Lumic
4 days ago

Nifty

Nifty IT Jumps 11.5% for Its Biggest Weekly Gain in Nearly 18 Years

  • Nifty IT gained 11.5% in a week, marking its biggest weekly rise in nearly 18 years
  • Tech Mahindra, TCS, Infosys and HCLTech were among the major stocks leading the rally
  • Better-than-expected quarterly results helped renew investor interest in Indian IT companies
LUMIC INSIGHT
With L&T, Infosys and Coforge results ahead, investors to watch IT ral
CnbcTv18·4 days ago